Inhibrx Inc (INBX)
34.09
-0.29
(-0.84%)
USD |
NASDAQ |
Apr 25, 16:00
34.11
+0.02
(+0.06%)
After-Hours: 20:00
Inhibrx Price to Book Value: 37.14 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 37.14 |
| April 24, 2024 | 37.45 |
| April 23, 2024 | 37.18 |
| April 22, 2024 | 37.15 |
| April 19, 2024 | 37.39 |
| April 18, 2024 | 37.53 |
| April 17, 2024 | 37.70 |
| April 16, 2024 | 37.70 |
| April 15, 2024 | 37.85 |
| April 12, 2024 | 38.11 |
| April 11, 2024 | 38.15 |
| April 10, 2024 | 38.10 |
| April 09, 2024 | 38.05 |
| April 08, 2024 | 37.80 |
| April 05, 2024 | 38.10 |
| April 04, 2024 | 37.75 |
| April 03, 2024 | 38.22 |
| April 02, 2024 | 37.97 |
| April 01, 2024 | 37.99 |
| March 28, 2024 | 38.09 |
| March 27, 2024 | 38.29 |
| March 26, 2024 | 38.21 |
| March 25, 2024 | 38.06 |
| March 22, 2024 | 38.01 |
| March 21, 2024 | 38.10 |
| Date | Value |
|---|---|
| March 20, 2024 | 38.13 |
| March 19, 2024 | 38.12 |
| March 18, 2024 | 38.06 |
| March 15, 2024 | 38.13 |
| March 14, 2024 | 38.12 |
| March 13, 2024 | 38.51 |
| March 12, 2024 | 38.39 |
| March 11, 2024 | 38.30 |
| March 08, 2024 | 38.72 |
| March 07, 2024 | 38.97 |
| March 06, 2024 | 38.90 |
| March 05, 2024 | 38.76 |
| March 04, 2024 | 38.83 |
| March 01, 2024 | 39.71 |
| February 29, 2024 | 39.90 |
| February 28, 2024 | 40.31 |
| February 27, 2024 | 43.10 |
| February 26, 2024 | 42.15 |
| February 23, 2024 | 41.70 |
| February 22, 2024 | 41.76 |
| February 21, 2024 | 41.70 |
| February 20, 2024 | 41.45 |
| February 16, 2024 | 41.04 |
| February 15, 2024 | 41.37 |
| February 14, 2024 | 40.92 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.291
Minimum
Oct 27 2023
80.18
Maximum
Jun 15 2023
26.71
Average
18.83
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 5.144 |
| Gilead Sciences Inc | 3.561 |
| Outlook Therapeutics Inc | -- |
| Axonics Inc | 5.323 |
| NovaBay Pharmaceuticals Inc | 1.699 |
Price to Book Value Related Metrics
| PS Ratio | 892.40 |
| PEG Ratio | -0.1607 |
| Price | 34.09 |
| Earnings Yield | -15.02% |
| Market Cap | 1.616B |
| PEGY Ratio | -0.1607 |